Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia
暂无分享,去创建一个
F. Glorieux | M. Peacock | J. Humphrey | M. Klausner | Takahiro Ito | Xiaoping Zhang | T. Weber | K. Insogna | T. Carpenter | A. Portale | E. Imel | Maria Vergeire | M. Ruppe